Tag: Checkpoint Therapeutics
Sun Pharma completes its acquisition of Checkpoint Therapeutics
As part of the acquisition, Sun Pharma acquires UNLOXCYTTM, the first and only FDA-approved anti-PD-L1 treatment for advanced cutaneous squamous cell carcinoma
Jubilant leverages its epigenetics edge through $180 million deal with Checkpoint...
In this recent deal sealed by Jubilant Biosys, it will out-license a family of patents covering compounds..